C-reactive protein (CRP) is a circular five body protein. The concentration of CRP in normal people's blood is very low, but it will rise rapidly under pressure conditions, such as infection, trauma, surgery, tissue necrosis and acute inflammation. In the absence of inflammation, allergic CRP is arteriosclerosis thrombus. The formed vectors and markers can be used to monitor potential cardiovascular risks and help diagnose cardiovascular diseases.
C-reactive protein: postoperative infection and complication monitoring; Monitoring the treatment of inflammation and the use of antibiotics; Differential diagnosis of bacterial / viral infection.
High sensitivity C-reactive protein: the most powerful predictor of cardiovascular disease, which can predict the risk index of myocardial infarction, coronary heart disease, stroke and other diseases. Differential diagnosis of neonatal infection.
Test results | Clinical application recommendations |
---|---|
>25 | Bacterial infections |
10~25 | In antibiotic treatment, the CRP of infected virus must be lower than this level. If the condition is short, bacterial infection cannot be ruled out, so it should be rechecked within a few hours. |
<10 | If the disease lasts for more than 6 ~ 12 hours, bacterial infection and sterilization can be basically ruled out. |
>2 | Prompt neonatal infection |
---|---|
Concentration drop | Effective, the state improved (D4 discount ≥ 40%), the blood pressure decreased to normal, and the antibiotic treatment was stopped |
Test results | Clinical application recommendations |
---|---|
>10 | It is recommended that bacterial infections can be ruled out |
0 50~100 | It is often bacterial infection, but virus infection is not common |
25~50 | Indicates bacterial or viral infection |
10~25 | In antibiotic treatment, the CRP of infected virus must be lower than this level. If the condition is short, bacterial infection cannot be ruled out, so it should be rechecked within a few hours. |
3~10 | Cardiovascular disease: high risk, it is recommended to give anti-inflammatory and antithrombotic therapy at the same time |
1~3 | Cardiovascular disease: moderate risk, anti-inflammatory treatment recommended, reexamination after 2 weeks, average observation standard |
<1 | Cardiovascular disease: low risk |
Treatment goals | hsCRP <1mg/L |
Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.